I shouldn’t be surprised that we’re here again.
“Here” is waiting to see whether the just announced intention by the current White House to kill the Affordable Care Act is going to pick up any steam. “Here” is wondering whether type II diabetes will be classified as a pre-existing condition somewhere down the line. “Here” questioning what I’d do if my insurance provider, suddenly unburdened by the regulations of Obamacare, would subject me to coverage limits.
And, ultimately, “here” is me on my bike later this year, riding in the Pittsburgh edition of the American Diabetes Association’s Tour de Cure and raising money so all of the other “heres” won’t matter.
I’ve talked to you guys about this stuff before, when I did the same ride up near Butler two years ago. At that point, we were in the first year of the Trump presidency and the future of Obamacare was uncertain, to say the least.
That part calmed down a bit — until very recently, anyway — but those worries were replaced by new ones … like the cost of the drugs people with diabetes rely on to manage the disease and, you know, keep us alive.
Back then, I was using injections of Lantus — a brand of insulin — each day as the primary treatment for the disease. I’m now using daily shots of Victoza to do the same thing. It helps — my latest A1C reading was 6.5, which is close to half of what it was when I was diagnosed — but it comes at a cost.
I am so fortunate — for me, that cost is largely borne by my insurance provider. If you’re underinsured, or if you have no insurance at all, you could find yourself on the hook for the full price of a three-pen box of Victoza — and that, boys and girls, costs just under $1,000. And you’d need 12 of those boxes to get you through a full year. Plain old insulin is a bargain by comparison, at $400 per box or roughly $1,200 a year.
Add to that the potential for losing insurance if the ACA goes away. Or being told by your insurance company that your rates are going to double because of your pre-existing condition. Or that we’re going to give you a thousand bucks a year to manage your diabetes, but you’re responsible for everything else after that. If that happens, even people who have good insurance could be in trouble.
The solution is the same now as it is then: Let’s not wait to see what happens in Washington. Let’s get the American Diabetes Association the money it needs to fund research and find a cure. Follow this link to my Tour de Cure page, where I will dazzle you with even more facts and, not coincidentally, you can make a donation. I’m hoping to raise $1,000, and anything you can give — ANYTHING — will be a huge help.